Human trials for a Covid-19 vaccine developed by Oxford University are beginning in South Africa and in Brazil.
Some 2,000 people in South Africa will be involved in what is widely considered to be one of the earliest and most advanced trials for a vaccine to tackle the pandemic.
The first doses of the vaccine are being administered in Johannesburg this week.
South Africa has been chosen, not just for its expertise in this field, but because Covid-19 is now spreading fast here.
That makes it far easier for scientists to find a community at immediate risk of infection, and to then tell whether this British vaccine is effective.
Similar tests are already underway in the UK, but the infection rate there is slowing. Hence the move, not just to South Africa, but to Brazil too, where 5,000 people will be involved in the vaccine trial.Article share tools
Latest Stories
-
Special Prosecutor Kissi Agyabeng facing impeachment
1 hour -
Mass wedding plans for Nigerian orphans spark outrage
1 hour -
Election 2024: Our situation may be bad, but better than being at war – Kofi Amoabeng
2 hours -
Parliament to reconvene today for an emergency sitting
2 hours -
Medikal to cover tuition fees for students on upcoming school tour
2 hours -
Cecilia Dapaah’s husband testifies in alleged $1m theft case
3 hours -
Ghana Shippers’ Authority takes steps to reduce the cost of cargo clearance
3 hours -
Stevie Wonder presented with Bridge Builder Award by Diaspora African Forum
3 hours -
Kusaal language goes live on Wikipedia
3 hours -
South Koreans compete to see who’s best at doing absolutely nothing
4 hours -
Scientists may have solved mystery behind Egypt’s pyramids
4 hours -
Court remands man over alleged theft of fuel dispensers
5 hours -
‘That was a lie!’ – Trump lawyer clashes with Michael Cohen in hush-money trial
5 hours -
MTN calls for rethink of tax structure
5 hours -
Chad’s Mahamat Deby confirmed as winner of disputed election
5 hours